Crucell Holland B.V.
Records under this name other than the patents Crucell Holland B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,005,831 | Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,968,092 | Human binding molecule against CD1a Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,470,327 | Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,611,317 | Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,701,718 | Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines Formerly held In force · High confidence | In force | High confidence | |
| US 9,593,159 | Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,452,211 | Influenza virus vaccines and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,969,778 | Influenza virus vaccines and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,476,061 | Adenoviral vectors for transduction of vascular tissue Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,294,279 | Stabilized soluble pre-fusion RSV F polypeptides Formerly held In force · USPTO record | In force | USPTO record |